Antithrombotic consultations encompass various conditions, such as: deep vein thrombosis (DVT) treatment, venous thromboembolism (VTE) prevention, atrial fibrillation, coronary heart disease, cerebral infarction, portal vein thrombosis, and superior mesenteric artery thrombosis.
Conditions
Interventions
Full Adoption Group:None
Non-adoption Group:None
Partial Adoption:None
Sponsors
HuNan University of Medicine General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.This study includes all consultation patients where clinical pharmacists participated primarily for antithrombotic treatment plan evaluation or adjustment. Specific sub-studies will focus on defined conditions, such as total hip/knee arthroplasty, traumatic intracerebral hemorrhage, and spontaneous intracerebral hemorrhage.
Exclusion criteria
Exclusion criteria: 1.Those without clinical pharmacist participation; 2.Consultations not primarily for antithrombotic management;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adoption of Consultation Recommendations; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient outcomes; | — |
Countries
China
Contacts
Public ContactJinyuanxiang
HuNan University of Medicine General Hospital
Outcome results
None listed